###begin article-title 0
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
###end article-title 0
###begin p 1
Conceived and designed the experiments: VD TC YI AM SL. Performed the experiments: VD TC YI FTC AL SM MPB PE PDC CK AB. Analyzed the data: VD TC YI JTVN PE RB YLMB PG AM SL. Contributed reagents/materials/analysis tools: VD TC YI SM MPB AZ PE PDC CK RB AB YLMB PG. Wrote the paper: YLMB PG AM SL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Obesity-associated inflammation is of critical importance in the development of insulin resistance and non-alcoholic fatty liver disease. Since the cannabinoid receptor CB2 regulates innate immunity, the aim of the present study was to investigate its role in obesity-induced inflammation, insulin resistance and fatty liver.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 309 313 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
Murine obesity models included genetically leptin-deficient ob/ob mice and wild type (WT) mice fed a high fat diet (HFD), that were compared to their lean counterparts. Animals were treated with pharmacological modulators of CB2 receptors. Experiments were also performed in mice knock-out for CB2 receptors (Cnr2 -/-).
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 368 371 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 376 380 376 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 587 590 587 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 641 645 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 819 823 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 933 937 933 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
In both HFD-fed WT mice and ob/ob mice, Cnr2 expression underwent a marked induction in the stromal vascular fraction of epididymal adipose tissue that correlated with increased fat inflammation. Treatment with the CB2 agonist JWH-133 potentiated adipose tissue inflammation in HFD-fed WT mice. Moreover, cultured fat pads isolated from ob/ob mice displayed increased Tnf and Ccl2 expression upon exposure to JWH-133. In keeping, genetic or pharmacological inactivation of CB2 receptors decreased adipose tissue macrophage infiltration associated with obesity, and reduced inductions of Tnf and Ccl2 expressions. In the liver of obese mice, Cnr2 mRNA was only weakly induced, and CB2 receptors moderately contributed to liver inflammation. HFD-induced insulin resistance increased in response to JWH-133 and reduced in Cnr2 -/- mice. Finally, HFD-induced hepatic steatosis was enhanced in WT mice treated with JWH-133 and blunted in Cnr2 -/- mice.
###end p 7
###begin title 8
Conclusion/Significance
###end title 8
###begin p 9
These data unravel a previously unrecognized contribution of CB2 receptors to obesity-associated inflammation, insulin resistance and non-alcoholic fatty liver disease, and suggest that CB2 receptor antagonists may open a new therapeutic approach for the management of obesity-associated metabolic disorders.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Despres1">[1]</xref>
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Parekh1">[3]</xref>
###xml 518 521 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Weisberg1">[4]</xref>
###xml 522 525 522 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Xu1">[7]</xref>
###xml 794 797 790 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Weisberg1">[4]</xref>
###xml 798 801 794 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Bertola1">[9]</xref>
###xml 1041 1045 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Postic1">[10]</xref>
###xml 1273 1276 1265 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Parekh1">[3]</xref>
Along with the alarming rise in obesity to epidemic proportions, related complications such as diabetes mellitus, insulin resistance, cardiovascular disease and non-alcoholic fatty liver disease (NAFLD) are also growing and represent some of the leading health-care concerns [1]-[3]. Several studies have conclusively demonstrated that a chronic low-grade systemic inflammatory state, predominantly arising from adipose tissue and liver, plays a critical role in the development of these obesity-related comorbidities [4]-[7]. Thus, in adipose tissue, fat laden adipocytes initiate the inflammatory response by producing cytokines and chemokines, including MCP-1, TNFalpha and osteopontin, that promote recruitment of proinflammatory macrophages and further amplification of local inflammation [4]-[9]. Increased adipose tissue inflammation will contribute to insulin resistance by disrupting insulin-dependent signaling pathways, leading to increased delivery of free fatty acids to the liver, and thereby contributing to hepatic steatosis [10]. Moreover, fatty liver itself also induces a local subacute inflammatory state characterized by production of inflammatory mediators such as TNFalpha or IL-6, that directly contribute to hepatic and systemic insulin resistance [3].
###end p 11
###begin p 12
###xml 127 142 127 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cannabis Sativa</italic>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-DiMarzo1">[11]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Pacher1">[13]</xref>
###xml 390 393 390 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-DiMarzo1">[11]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Kunos1">[14]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Klein1">[15]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Klein1">[15]</xref>
###xml 826 830 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Batkai1">[18]</xref>
Cannabinoid receptors CB1 and CB2 belong to the family of G protein-coupled receptors, and bind exogenous ligands derived from Cannabis Sativa as well as endogenous arachidonic-derived ligands (endocannabinoids) among which anandamide or 2-arachidonoylglycerol are the best characterized [11]-[13]. CB1 receptors play a key role in the pathogenesis of obesity, insulin resistance and NAFLD via central and peripheral effects [11], [14]. CB2 receptors are primarily expressed in cells of the immune system, including macrophages, and regulate the inflammatory response in various settings [15]. Thus, preclinical studies have demonstrated the critical role of CB2 receptors in the inflammatory process associated with rheumatoid arthritis, inflammatory bowel diseases, atherosclerosis or liver ischemia-reperfusion injury [15]-[18]. The aim of the present study was therefore to investigate the role of CB2 receptors in obesity-associated inflammation, insulin resistance and NAFLD.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Animals and Experimental Design
###end title 14
###begin p 15
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Buckley1">[19]</xref>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 582 586 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 594 620 583 609 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGTGCTGCTCATATGCTGG-3&#8242;</named-content>
###xml 632 658 621 647 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAGAGCGAATCTCTCCACT-3&#8242;</named-content>
###xml 682 686 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 762 766 751 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 774 801 763 790 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCCTGGCACCTCTTTCTCAG-3&#8242;</named-content>
###xml 813 840 802 829 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTCTCCTGCTGGAACCAACGG-3&#8242;</named-content>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 756 761 <span type="species:ncbi:10090">mouse</span>
Mice used for the experiments included wild type (WT) C57Bl/6J, ob/ob and ob+/ob male mice (Janvier, France) and mice with a targeted mutation of the Cnr2 gene [19]. To obtain single mutant mice on an inbred congenic genetic background, heterozygous Cnr2 +/- mice were backcrossed with WT C57Bl/6J (The Jackson Laboratory) animals over 10 generations. Heterozygous mice from the N10 generation were intercrossed to homozygous Cnr2 -/- animals. Genotyping was performed on tail genomic DNA using QuantiTecttrade mark SYBR(R) Green PCR kit (Qiagen), with the following primers: mouse Cnr2: sense 5'-CTGTGCTGCTCATATGCTGG-3', antisense 5'-GCAGAGCGAATCTCTCCACT-3'. We also verified that Cnr2 -/- mice still expressed CB1 receptors, using the following primers: mouse Cnr1: sense 5'-CTCCTGGCACCTCTTTCTCAG-3', antisense 5'-GTCTCCTGCTGGAACCAACGG-3'.
###end p 15
###begin p 16
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
Experimental protocols were conducted in accordance with French government policies (Services veterinaires de la Sante et de la production animale, Ministere francais de l'Agriculture). Adult male mice were housed under 12 hours of light/12 hours of dark cycle, in a temperature-controlled environment. WT C57Bl/6J mice and Cnr2 -/- mice (7-10 week-old) were fed a standard chow (TD 2016, Harlan) or a high fat diet (36% fat, TD 99249, Harlan) for 6 or 15 weeks, as indicated. Body weight and food intake were measured weekly.
###end p 16
###begin p 17
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 334 340 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 699 704 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 715 721 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">Mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
The impact of the CB2 agonist JWH-133 (Tocris, France) was evaluated in 8-week-old C57Bl/6J mice under ND or HFD for 6 weeks that were treated with JWH-133 during the last 15 days. In some experiments, the effect of the CB2 antagonist AM-630 (Tocris, France) was evaluated in 6-week-old obese male mice (ob/ob) and lean counterparts (ob+/ob). JWH-133 and AM-630 were freshly dissolved in a vehicle solution containing 1 drop of Tween 20 in 0.1 ml dimethylsulfoxide (DMSO), sonicated, and further diluted 50 times in NaCl 9per thousand. Mice received a 15-day course of daily JWH-133 (3 mg/kg) intraperitoneal injection (n = 10 HFD-fed WT mice, and n = 6 ND-fed WT mice) or of 1 mg/kg AM-630 (n = 10 ob/ob and n = 5 ob+/ob). Control animals were treated in parallel with vehicle. Body weight and food intake were measured daily.
###end p 17
###begin p 18
###xml 24 28 <span type="species:ncbi:10090">mice</span>
In all the experiments, mice were sacrificed after overnight fasting. White epididymal adipose tissue and liver were removed, weighed and either fixed in buffered formalin, or snap frozen in liquid nitrogen. All samples were stored at -80degreesC until use.
###end p 18
###begin title 19
Preparation of adipocyte and stromal vascular fraction (SVF) from adipose tissue
###end title 19
###begin p 20
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 121 122 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 124 125 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 136 137 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 154 155 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 168 169 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 583 587 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 592 598 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Adipoq</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Epididymal adipose tissues from ob+/ob and ob/ob mice were chopped and rinsed in buffer A containing 120 mM NaCl, 4 mM KH2PO4, 1 mM MgSO4, 750 microM CaCl2, 10 mM NaHCO3 and 30 mM HEPES pH 7.4. Explants were incubated at 37degreesC for 30 minutes in 10 ml of buffer A supplemented with 1% BSA, 280 mM glucose and 15 mg of type 1 collagenase (Clostrido peptidase A, Sigma). Adipocytes were then collected by filtration and floatation, and the SVF was obtained following further centrifugation for 15 min at 260 g and two washings in buffer A. Purity of the fractions was evaluated by Emr1 and Adipoq expressions (not shown). All samples were stored at -80degreesC until use.
###end p 20
###begin title 21
Preparation of hepatocyte and non parenchymal liver cell fraction
###end title 21
###begin p 22
###xml 12 18 12 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Livers from ob+/ob and ob/ob mice were perfused in vivo by Liberase(R) (Roche) through portal vein. Livers were then dissociated with forceps in Williams medium contanining 10% FCS. Hepatocytes were obtained after filtration and sedimentation while the supernatant was centrifugated at 300 g for 10 min to obtain the non parenchymal cell fraction.
###end p 22
###begin title 23
Adipose tissue and liver histology
###end title 23
###begin p 24
###xml 270 274 266 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 438 442 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
Fat and liver specimens were fixed in 10% formalin, paraffin-embedded and tissue sections (8 and 4 microm, respectively) were stained with hematoxylin-eosin for routine examination. Adipocyte size was quantified on at least 30 cells from 3 separate fields in 7 WT and 5 Cnr2 -/- HFD-fed animals, using Image J software. Hepatic steatosis was blindly assessed on 4 random fragments from different areas of each liver (n = 10 WT and n = 10 Cnr2 -/- HFD-fed animals), and was staged on a scale of 0 to 4, according to the percentage of hepatocytes containing cytoplasmic vacuoles as follows: 0, (<5%), 1 (5-20%), 2 (20%-30%), 3 (30-60%), 4 (>/=60%).
###end p 24
###begin title 25
Indirect calorimetry
###end title 25
###begin p 26
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Even1">[20]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Even2">[21]</xref>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;</italic>
###xml 635 639 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Even2">[21]</xref>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
In vivo indirect open circuit calorimetry was performed as previously described [20], [21]. Briefly, the mice (HFD-fed WT (n = 7) and HFD-fed Cnr2-/- (n = 7)) were housed individually in the metabolic cage at 09:30 with water, but without food. Temperature in the metabolic cage was maintained at 32degreesC+/-0.5 (low range of thermoneutrality), with an artificial 12 h-12 h light-dark cycle. Respiratory exchanges and spontaneous activity were continuously recorded at 10 s interval from 10:00 until 09:00 the following day. Resting and activity-related metabolic rates were calculated a posteriori using the Kalman filtering method [21]. Basal metabolic rate and basal RQ were defined as the mean resting metabolic rate measured between 16:00 and 18:00 when the mice were in a post-absorptive state, just before the 1g-test meal was given. Post meal RQ was defined as the mean RQ measured during 6 hrs following administration of the 1g-test meal (until metabolic rate returned to pre-meal values); peak post meal is defined as the highest value of RQ recorded during the post meal period. Energy expended with activity was calculated from the difference between total and resting metabolism.
###end p 26
###begin title 27
Fecal fat excretion
###end title 27
###begin p 28
###xml 51 55 <span type="species:ncbi:10090">mice</span>
The amount of fat in dried feces (n = 7 cages of 5 mice in each group) was measured by the Laboratory of Functional Coprology, Pitie-Salpetriere Hospital, Paris France.
###end p 28
###begin title 29
Culture of explants from adipose tissue
###end title 29
###begin p 30
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 169 170 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Explants of epididymal adipose tissue were prepared from ob/ob male mice, following overnight fasting. Epididymal adipose tissue samples were cut into small pieces (1 mm3) under sterile conditions and rinsed in Dulbecco's modified Eagle medium (DMEM, Invitrogen). Explants (200 mg) were further incubated for 48 hours at 37degreesC in DMEM supplemented with 12.5 mM glucose, 200 IU/ml penicillin, 50 mg/l streptomycin, and 2% BSA, and further exposed to 1 microM JWH-133 (Tocris, France) or vehicle (DMSO 0.02%). After 48 hours, samples were frozen in liquid nitrogen and stored at -80degreesC before RNA extraction.
###end p 30
###begin title 31
Serum analysis
###end title 31
###begin p 32
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
Blood was collected at the time of sacrifice, fasting glycemia were determined by Accu-Check active bands (Roche Diagnostics) and insulinemia by Elisa (Ultrasensitive mouse sensitive Elisa, Mercodia), respectively.
###end p 32
###begin title 33
Hepatic triglyceride quantification
###end title 33
###begin p 34
Hepatic triglycerides were extracted from 50 mg of liver homogenates by homogenization in 1 ml of chloroform-methanol (2:1 v/v) using TissueLyser (Qiagen). The homogenate was centrifuged for 10 min at 1000 g, and the lipid phase was diluted with 0.2 ml water. Following an additional centrifugation for 20 min at 2400 rpm, the lipid extract was collected from the lower phase, evaporated and dissolved in 1 ml of 2-propanol. Triglycerides were quantified with a triglyceride determination kit (Sigma), on liver samples from 10-15 animals per group.
###end p 34
###begin title 35
Insulin tolerance test
###end title 35
###begin p 36
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 62 67 <span type="species:ncbi:9606">human</span>
Mice (7-10 per group) underwent a 0.75 U/kg i.p. injection of human insulin (Insulin NPH; Lilly), following a 3 h fasting. Blood samples were taken from the tail vein for determination of glycemia at time 0 and 20, 30, 40, 60, 90, 120, and 180 min after the insulin injection.
###end p 36
###begin title 37
Hyperinsulinemic-euglycemic clamp
###end title 37
###begin p 38
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Knauf1">[22]</xref>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 211 213 211 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 264 266 260 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 270 273 266 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1)</sup>
###xml 327 328 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 582 583 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 760 761 752 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 839 840 831 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 879 883 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Knauf1">[22]</xref>
###xml 1040 1041 1032 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
Hyperinsulinemic- euglycemic clamp was performed as previously described [22]. Briefly, 6h-fasted WT (n = 6) and Cnr2 -/- (n = 7) mice fed a HFD for 15 weeks, received simultaneous infusions of insulin (18 mU.kg-1.min-1 for 3 h), and D-(3H)3-glucose (30 microCi.kg-1.min-1), Perkin Elmer, Boston, MA) to ensure a detectable D-(3H)3-glucose enrichment. Glycemia was assessed throughout the infusion from blood samples collected from the tip of the tail vein and euglycemia was maintained by adjusting a variable infusion of 30% (wt/vol) glucose. Plasma glucose concentrations and D-(3H)3-glucose specific activity were determined in 5 microl of blood sampled from the tip of the tail vein every 10 min during the last hour of the infusion. The enrichment in D-(3H)3-glucose was determined from total blood after deproteinization by a Zn(OH)2 precipitation as previously described [22]. An aliquot of the protein-free supernatant was evaporated to dryness and mixed with scintillation fluid to determine the radioactivity corresponding to D-[3H]3-glucose. In a second aliquot of the same supernatant, glucose concentration was measured by the glucose oxidase method (Sigma).
###end p 38
###begin title 39
RNA preparation and RT-PCR
###end title 39
###begin p 40
###xml 213 217 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Julien1">[23]</xref>
###xml 305 310 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rn18S</italic>
###xml 312 317 310 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sense</bold>
###xml 317 345 315 343 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACCAGAGCGAAAGCATTTGCCA-3&#8242;</named-content>
###xml 347 356 345 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">antisense</bold>
###xml 358 386 356 384 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATCGCCAGTCGGCATCGTTTAT-3&#8242;</named-content>
###xml 394 398 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 400 405 398 403 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sense</bold>
###xml 405 431 403 429 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGATACAGAATAGCCAGGAC-3&#8242;</named-content>
###xml 433 442 431 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">antisense</bold>
###xml 442 468 440 466 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGCCGTTGGTCACTTCTG-3&#8242;</named-content>
###xml 476 480 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 482 487 480 485 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sense</bold>
###xml 487 513 485 511 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGCAAATTTCCTTGTAGCA-3&#8242;</named-content>
###xml 515 524 513 522 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">antisense</bold>
###xml 524 554 522 552 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGCAAGGCCGTCTAAGATCGACT-3&#8242;</named-content>
###xml 562 566 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 568 573 566 571 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sense</bold>
###xml 573 598 571 596 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGGCCTGCTGTTCACAGTT-3&#8242;</named-content>
###xml 600 609 598 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">antisense</bold>
###xml 609 634 607 632 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAGCCTACTCATTGGGAT-3&#8242;</named-content>
###xml 642 646 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 648 653 646 651 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sense</bold>
###xml 653 681 651 679 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTTGGCTATGGGCTTCCAGTC-3&#8242;</named-content>
###xml 683 692 681 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">antisense</bold>
###xml 692 722 690 720 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAAGGAGGACAGAGTTTATCGTG-3&#8242;</named-content>
###xml 730 733 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 735 740 733 738 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sense</bold>
###xml 740 768 738 766 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATGGCCTCCCTCTCATCAGTT-3&#8242;</named-content>
###xml 770 779 768 777 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">antisense</bold>
###xml 779 806 777 804 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCACTTGGTGGTTTGCTACGA-3&#8242;</named-content>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 299 304 <span type="species:ncbi:10090">mouse</span>
###xml 388 393 <span type="species:ncbi:10090">mouse</span>
###xml 470 475 <span type="species:ncbi:10090">mouse</span>
###xml 556 561 <span type="species:ncbi:10090">mouse</span>
###xml 636 641 <span type="species:ncbi:10090">mouse</span>
###xml 724 729 <span type="species:ncbi:10090">mouse</span>
Total RNA was extracted from mice epididymal fat, liver and brain using RNeasy(R) Lipid Tissue Mini kit (Qiagen). Quantitative RT-PCR was carried out on a Light Cycler (Roche Diagnostics), as previously described [23]. Oligonucleotide primer sequences of the mouse genes studied were the following. mouse Rn18S: sense5'-ACCAGAGCGAAAGCATTTGCCA-3', antisense: 5'-ATCGCCAGTCGGCATCGTTTAT-3'; mouse Cnr2: sense5'-GGATACAGAATAGCCAGGAC-3', antisense5'-GGAGCCGTTGGTCACTTCTG-3'; mouse Cnr1: sense5'-GGGCAAATTTCCTTGTAGCA-3', antisense5'-CTGCAAGGCCGTCTAAGATCGACT-3'; mouse Ccl2: sense5'-GGGCCTGCTGTTCACAGTT-3', antisense5'-CCAGCCTACTCATTGGGAT-3'; mouse Emr1: sense5'-CTTTGGCTATGGGCTTCCAGTC-3', antisense5'-GCAAGGAGGACAGAGTTTATCGTG-3'; mouse Tnf: sense5'-AATGGCCTCCCTCTCATCAGTT-3', antisense5'-CCACTTGGTGGTTTGCTACGA-3'. PCR amplified products were analyzed on a 2% agarose gel and sequenced.
###end p 40
###begin title 41
Immunohistochemistry
###end title 41
###begin p 42
###xml 618 622 614 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
Immunohistochemical detection of F4/80 was performed in epididymal adipose formalin-fixed, parraffin-embedded tissue sections (8 microm), using non-diluted antibody to F4/80 (Serotec MCA 497) and biotinylated secondary antibody (1/50, Serotec AAR10B). The signal was amplified with phosphatase alkaline-conjugated streptavidin (1/20, Serotec), and alkaline phosphatase activity was revealed using fast red substrate-chromogen system (Dakocytomation). The total number of F4/80 expressing cells was quantified on at least 500 cells from 5 random fields in 7 vehicle-treated or 7 AM-630-treated WT mice fed a HFD, and 5 Cnr2 -/- HFD-fed animals, using Image J software. Results are expressed as F4/80 stained cells/total cells.
###end p 42
###begin title 43
Statistics
###end title 43
###begin p 44
###xml 150 151 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Results are expressed as mean+/-SEM and were analyzed by either Mann and Whitney test, one or two way ANOVA as appropriate, using PRISM 4.0 software. P<0.05 was taken as the minimum level of significance.
###end p 44
###begin title 45
Results
###end title 45
###begin title 46
Characterization of CB2 receptor expression in the adipose tissue and the liver during obesity
###end title 46
###begin p 47
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 456 462 456 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 1A</bold>
###xml 456 462 456 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g001"><bold>Fig 1A</bold></xref>
###xml 512 516 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 634 638 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 686 692 686 692 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 1A</bold>
###xml 686 692 686 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g001"><bold>Fig 1A</bold></xref>
###xml 771 775 771 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 851 857 851 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 868 873 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 936 942 936 942 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 1B</bold>
###xml 936 942 936 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g001"><bold>Fig 1B</bold></xref>
###xml 1003 1007 1003 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 1041 1046 1041 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1068 1074 1068 1074 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 1C</bold>
###xml 1068 1074 1068 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g001"><bold>Fig 1C</bold></xref>
###xml 1125 1129 1125 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 1205 1211 1205 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 1225 1230 1225 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1248 1252 1248 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 1303 1309 1303 1309 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 1D</bold>
###xml 1303 1309 1303 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g001"><bold>Fig 1D</bold></xref>
###xml 1366 1370 1366 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
We first characterized the expression of Cnr2 (encoding CB2) in the adipose tissue and in the liver, and its regulation overtime during obesity, using genetically obese leptin-deficient ob/ob mice and wild type (WT) C57Bl/6J mice fed a high fat diet (HFD) for 6 or 15 weeks. In the two models, Cnr2 expression was detected in the epididymal adipose tissue of lean animals, and its expression was enhanced in obese mice in parallel to body weight increase (Fig 1A). Moreover, in both models, the induction of fat Cnr2 expression was correlated with adipose tissue inflammation, as shown by the concurrent increase in the expression of Emr1, encoding the macrophage related marker F4/80 (Fig 1A). In keeping, epididymal adipose tissue fractionation experiments showed that Cnr2 was predominantly expressed in the stromal vascular fraction, both in lean ob+/ob and obese ob/ob animals, and was barely detectable in the adipocyte fraction (Fig 1B). Obesity was associated with a modest 1.8-fold increase in Cnr2 expression in the liver, both in ob/ob and HFD-fed animals (Fig 1C). In keeping with findings in the adipose tissue, Cnr2 was primarily expressed by the non parenchymal liver cell fraction in lean ob+/ob and in obese ob/ob animals, whereas Cnr2 was hardly detectable in the hepatocyte fraction (Fig 1D). Overall, these results indicate that obesity enhances Cnr2 expression in the non parenchymal cell fraction of adipose tissue and liver.
###end p 47
###begin title 48
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
Selective distribution of Cnr2 in the adipose tissue and regulation during obesity.
###end title 48
###begin p 49
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 426 432 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 451 459 451 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob vs</italic>
###xml 472 478 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
A, Time course of Cnr2 and Emr1 expression in the epididymal adipose tissue of obese ob/ob and HFD-fed WT mice and corresponding body weight. B, Cnr2 expression was quantified in the SVF and adipocyte fraction of ob/ob and ob+/ob mice. C, Time course of Cnr2 expression in the liver of obese ob/ob and HFD-fed WT mice. D, Cnr2 expression was quantified in the non parenchymal and parenchymal liver cell fractions of ob/ob and ob+/ob mice. *p<0.05 for ob/ob vs age-matched ob+/ob mice or for HFD-fed vs age-matched ND-fed mice.
###end p 49
###begin title 50
CB2 receptors promote obesity-associated inflammation
###end title 50
###begin p 51
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Klein1">[15]</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Huffman1">[24]</xref>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Defer1">[25]</xref>
###xml 575 581 575 581 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 2A</bold>
###xml 575 581 575 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g002"><bold>Fig 2A</bold></xref>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 681 684 681 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 724 728 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 778 784 778 784 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 2B</bold>
###xml 778 784 778 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g002"><bold>Fig 2B</bold></xref>
###xml 854 858 854 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 863 866 863 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 927 933 927 933 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 2B</bold>
###xml 927 933 927 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g002"><bold>Fig 2B</bold></xref>
###xml 997 1001 997 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 1006 1009 1006 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 1030 1036 1030 1036 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 2B</bold>
###xml 1030 1036 1030 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g002"><bold>Fig 2B</bold></xref>
###xml 1083 1087 1083 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 1132 1138 1132 1138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 2B</bold>
###xml 1132 1138 1132 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g002"><bold>Fig 2B</bold></xref>
###xml 1220 1225 1220 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1303 1306 1303 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 1311 1315 1311 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 1329 1335 1329 1335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 2C</bold>
###xml 1329 1335 1329 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g002"><bold>Fig 2C</bold></xref>
###xml 1422 1426 1422 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 1431 1434 1431 1434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 1460 1466 1460 1466 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 2D</bold>
###xml 1460 1466 1460 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g002"><bold>Fig 2D</bold></xref>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 841 845 <span type="species:ncbi:10090">mice</span>
###xml 1126 1130 <span type="species:ncbi:10090">mice</span>
###xml 1226 1230 <span type="species:ncbi:10090">mice</span>
###xml 1363 1367 <span type="species:ncbi:10090">mice</span>
Given the regulatory role of Cnr2 in inflammation [15], we next explored the possibility that CB2 receptors may regulate fat and liver inflammation. To that aim, C57Bl/6J mice were fed a HFD or a normal diet (ND) and sacrificed after 6 weeks, i.e at the early onset of inflammation in obese mice. In addition, both groups of mice received a daily intraperitoneal injection of the selective CB2 receptor agonist JWH-133 (3 mg/kg) or its vehicle during the last 2 weeks [24], [25]. Administration of JWH-133 did not affect body weight progression of either HFD or ND-fed mice (Fig 2A). As expected, vehicle-treated HFD-fed mice showed a moderate induction of epididymal fat Emr1 and Tnf expressions, whereas the expression of Ccl2, encoding MCP-1, was already strongly increased (Fig 2B). Interestingly, administration of JWH-133 to ND-fed WT mice induced Emr1 and Tnf expression, as compared to vehicle-treated ND counterparts (Fig 2B). Moreover, the compound further potentiated inductions of fat Emr1 and Tnf in HFD-fed animals (Fig 2B). However, JWH-133 treatment had no effect on Ccl2 expression either in ND or in HFD-fed mice (Fig 2B). The impact of JWH-133 was also investigated in cultured fat pads isolated from ob/ob mice. Cultured fat pads exposed to JWH-133 showed a marked induction in both Tnf and Ccl2 expressions (Fig 2C). Finally, in the liver of mice fed a ND or a HFD, JWH-133 had little or no effect on Ccl2 and Tnf expression respectively (Fig 2D). Taken together, these data demonstrate that the role of CB2 receptor is critical in adipose tissue inflammation, but less determinant in liver inflammation.
###end p 51
###begin title 52
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Activation of CB2 receptors by JWH-133 enhances fat inflammation in HFD-fed mice.
###end title 52
###begin p 53
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 267 270 267 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 431 443 427 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf and Ccl2</italic>
###xml 481 486 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 574 578 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 580 583 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 588 592 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 685 687 681 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 717 719 713 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
WT mice were fed a HFD or a ND for 6 weeks, and treated with JWH-133 (3 mg/kg) or vehicle i.p daily during the last 15 days. A, Body weight progression during JWH-133 treatment. B, JWH-133 increases adipose tissue inflammation. Fold induction of adipose tissue Emr1, Tnf and Ccl2 expression over control conditions (ND-fed mice injected with vehicle). C, Activation of CB2 receptors with 1 microM JWH-133 for 48 hours up-regulates Tnf and Ccl2 expression in explants isolated from ob/ob mice fat pads. D, Impact of JWH-133 on hepatic inflammation. Fold induction of hepatic Emr1, Tnf and Ccl2 expression over control conditions (ND-fed mice injected with vehicle). *p<0.05 for JWH-133 vs vehicle. #p<0.05 for HFD-fed vs ND-fed mice.
###end p 53
###begin p 54
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Pertwee1">[26]</xref>
###xml 226 232 226 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 3A</bold>
###xml 226 232 226 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g003"><bold>Fig 3A</bold></xref>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 365 368 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 390 402 390 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 3B and C</bold>
###xml 390 402 390 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g003"><bold>Fig 3B and C</bold></xref>
###xml 431 437 431 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 563 575 563 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 3B and C</bold>
###xml 563 575 563 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g003"><bold>Fig 3B and C</bold></xref>
###xml 610 617 610 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;/&#8722;</italic>
###xml 684 691 684 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;/&#8722;</italic>
###xml 761 767 761 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 4A</bold>
###xml 761 767 761 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g004"><bold>Fig 4A</bold></xref>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 801 804 801 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 815 821 815 821 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 4B</bold>
###xml 815 821 815 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g004"><bold>Fig 4B</bold></xref>
###xml 851 858 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;/&#8722;</italic>
###xml 941 947 941 947 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 4C</bold>
###xml 941 947 941 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g004"><bold>Fig 4C</bold></xref>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 859 863 <span type="species:ncbi:10090">mice</span>
We next investigated whether CB2 receptor antagonism reduced obesity-associated inflammation. A 2-week treatment of ob/ob mice with the CB2 receptor antagonist AM-630 (1 mg/kg/day) did not affect body weight progression [26] (Fig 3A) while reducing adipose tissue inflammation, as reflected by the reduction in the accumulation of F4/80 positive cells and of Emr1, Tnf and Ccl2 expression (Fig 3B and C). Moreover, in control lean ob+/ob mice there was a trend towards reduced fat inflammation in AM-630 treated animals compared to lean vehicle-exposed controls (Fig 3B and C). These results were confirmed in Cnr2-/- mice fed a HFD for 15 weeks. Compared to HFD-fed WT mice, HFD-fed Cnr2-/- animals exhibited a significant reduction in fat macrophage density (Fig 4A) and a lesser induction of Emr1, Tnf and Ccl2 (Fig 4B). Finally, livers of HFD-fed Cnr2-/- mice also showed a decline in inflammation, as compared to their WT counterparts (Fig 4C). Overall, these data demonstrate that CB2 receptor inactivation reduces inflammation both in adipose tissue and in the liver of obese animals.
###end p 54
###begin title 55
Pharmacological inactivation of CB2 receptors reduces the inflammatory response in the adipose tissue.
###end title 55
###begin p 56
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 348 351 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 356 360 356 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 397 403 397 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob+/ob</italic>
###xml 452 454 452 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 476 491 476 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob vs ob+/ob</italic>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
ob/ob and ob+/ob mice were daily treated for 15 days with an intraperitoneal injection of AM-630 (1 mg/kg) or vehicle. A, Body weight progression of AM-630 and vehicle-treated ob/ob mice over time. B, C AM-630 reduces adipose tissue inflammation, as assessed by quantification of fat F4/80 stained cells/total cells and fold induction of fat Emr1, Tnf and Ccl2 expression over control conditions (ob+/ob mice injected with vehicle). *p<0.05 for AM-630 vs vehicle. #p<0.05 for ob/ob vs ob+/ob mice.
###end p 56
###begin title 57
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
Cnr2 knock-out reduces the inflammatory response in the adipose tissue and the liver.
###end title 57
###begin p 58
###xml 7 11 7 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 276 279 276 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Emr1</italic>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 377 380 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 565 569 565 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 574 576 574 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 616 618 616 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
WT and Cnr2 -/- mice were fed a HFD or a ND for 15 weeks. A, Macrophage infiltration into epididymal fat was assessed by immunohistochemical detection of F4/80 (magnification x400) and quantification of F4/80 stained cells/total cells. B, Fold induction of fat Emr1, Ccl2 and Tnf expression over control conditions (ND-fed WT mice). C, Fold induction of hepatic Emr1, Ccl2 and Tnf expression over control conditions (ND-fed WT mice). D, Body weight progression over time of WT and Cnr2 -/- mice fed a HFD for 15 weeks (p<0.05 by two way ANOVA). *p<0.05 for HFD-fed Cnr2 -/- vs HFD-fed WT mice. #p<0.05 in HFD-fed WT vs ND-fed WT mice.
###end p 58
###begin title 59
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
Deletion of Cnr2 reduces body weight progression under HFD
###end title 59
###begin p 60
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 160 166 160 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 4D</bold>
###xml 160 166 160 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g004"><bold>Fig 4D</bold></xref>
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 278 285 278 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 278 285 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005844-t001"><bold>Table 1</bold></xref>
###xml 376 383 376 383 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 376 383 376 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005844-t001"><bold>Table 1</bold></xref>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
Surprisingly, Cnr2 knock-out was also associated with a slower body weight progression that becomes significant after 8 weeks of HFD (p<0.05 by two way ANOVA) (Fig 4D). Accordingly, Cnr2 -/- mice also displayed smaller adiposity index and adipocyte size compared to WT animals (Table 1), and reduced circulating leptin levels, whereas serum adiponectin levels were unchanged (Table 1). Subsequent experiments investigated mechanisms underlying Cnr2 impact on obesity.
###end p 60
###begin title 61
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Metabolic parameters of HFD WT and Cnr2 -/- mice.
###end title 61
###begin p 62
###xml 7 9 7 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
p<0.05 vs HFD WT.
###end p 62
###begin p 63
###xml 7 9 7 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
p<0.01 vs HFD WT.
###end p 63
###begin p 64
###xml 8 10 8 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
p<0.001 vs HFD WT.
###end p 64
###begin p 65
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;</italic>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 403 411 403 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 455 462 455 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 455 462 455 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005844-t001"><bold>Table 1</bold></xref>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 704 712 704 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 1016 1023 1016 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;/&#8722;</italic>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
###xml 1024 1028 <span type="species:ncbi:10090">mice</span>
Since the cannabinoid receptor CB1 plays a key role in the pathogenesis of obesity by increasing food intake and reducing energy expenditure, we first characterized Cnr1 expression in brain, adipose tissue and liver. There was no difference in brain Cnr1 expression between HFD-fed WT and Cnr2-/- mice. However, surprisingly, Cnr1 expression was decreased in the adipose tissue and the liver of HFD-fed Cnr2 -/- mice as compared to their WT counterparts (Table 1). In contrast, livers and adipose tissue isolated from JWH-133 or AM-630 treated animals showed no difference in Cnr1 levels (not shown). These data suggested that the reduction of Cnr1 expression in the adipose tissue and liver observed in Cnr2 -/- mice might account for the reduction in body weight progression in these animals, a reduction that is not observed in WT mice treated with pharmacological agonists or antagonists of CB2 receptors. The next series of experiments were therefore designed to further delineate the mechanisms underlying the Cnr2-/- mice phenotype.
###end p 65
###begin p 66
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr1</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;</italic>
###xml 173 180 173 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005844-t001"><bold>Table 1</bold></xref>
###xml 224 232 224 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 339 346 339 346 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 339 346 339 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005844-t001"><bold>Table 1</bold></xref>
###xml 423 430 423 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;/&#8722;</italic>
###xml 693 701 693 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 727 734 727 734 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 727 734 727 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005844-t001"><bold>Table 1</bold></xref>
###xml 763 767 763 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 973 981 973 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 1019 1020 1019 1020 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1020 1027 1020 1027 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1020 1027 1020 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005844-t001"><bold>Table 1</bold></xref>
###xml 1027 1028 1027 1028 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1178 1182 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
###xml 982 986 <span type="species:ncbi:10090">mice</span>
Several studies have reported that Cnr1 knock-out decreases food intake and increases energy expenditure. However, food intake was similar in Cnr2-/- and WT mice fed a HFD (Table 1). Indirect calorimetry showed that HFD-fed Cnr2 -/- and WT mice had similar basal and total metabolic rate, exhibited the same level of spontaneous activity (Table 1), and equivalent thermogenic response to feeding (not shown). Nevertheless, Cnr2-/- mice tended to display a lower pre-meal, post meal and overall respiratory quotient, although the differences with WT animals did not reach statistical significance (data not shown). In addition, the peak of meal-induced RQ increase was significantly reduced in Cnr2 -/- animals, compared to WT (Table 1), therefore indicating that Cnr2 knock-out may reduce the inhibition of lipid oxidation induced by feeding. Finally, quantification of fat elimination in faeces showed a modest albeit significant increase in fecal lipid output in HFD-fed Cnr2 -/- mice, as compared to WT counterparts (Table 1), by a mechanism that may involve inhibition of pancreatic lipase gene expression (Cadoudal et al, preliminary results). Overall, these data indicate Cnr2 knock-out attenuates the progression of obesity by a mechanism distinct from that elicited by CB1 antagonism, possibly by increasing both lipid oxidation and fecal fat excretion.
###end p 66
###begin title 67
CB2 receptors promote insulin resistance
###end title 67
###begin p 68
###xml 249 255 249 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 5A</bold>
###xml 249 255 249 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g005"><bold>Fig 5A</bold></xref>
###xml 356 364 356 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 370 371 370 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 371 377 371 377 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 5A</bold>
###xml 371 377 371 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g005"><bold>Fig 5A</bold></xref>
###xml 454 462 454 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 550 556 550 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 5B</bold>
###xml 550 556 550 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g005"><bold>Fig 5B</bold></xref>
###xml 649 650 649 650 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 650 656 650 656 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 5C</bold>
###xml 650 656 650 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g005"><bold>Fig 5C</bold></xref>
###xml 656 657 656 657 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 730 738 730 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 843 847 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 858 859 858 859 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 859 865 859 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 5C</bold>
###xml 859 865 859 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g005"><bold>Fig 5C</bold></xref>
###xml 1055 1056 1055 1056 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1056 1061 1056 1061 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 5</bold>
###xml 1056 1061 1056 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g005"><bold>Fig 5</bold></xref>
###xml 1061 1064 1061 1064 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> D)</bold>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
We next examined the impact of CB2 receptors on obesity-associated insulin resistance, a reported consequence of inflammation. As expected, WT mice fed a HFD for 15 weeks developed hyperglycemia and hyperinsulinemia, resulting in increased HOMA-IR (Fig 5A). In contrast, the increase in insulin plasma levels and HOMA-IR was significantly lower in HFD-fed Cnr2 -/- mice (Fig 5A). Consistent with these results, insulin tolerance test showed that HFD-fed Cnr2 -/- mice were more insulin sensitive than their WT counterparts (p<0.05 by two way ANOVA) (Fig 5B). These findings were further corroborated in hyperinsulinemic-euglycemic clamp experiments (Fig 5C). Indeed, glucose turnover and glycolysis rate were increased in HFD-fed Cnr2 -/- mice, whereas glycogen synthesis rate remained unchanged, confirming the insulin sensitizing effects of Cnr2 knock-out (Fig 5C). Accordingly, in mice exposed to a HFD for 6 weeks, treatment with the CB2 agonist JWH-133 enhanced insulin resistance, as assessed by the insulin tolerance test (p<0.05 by two way ANOVA) (Fig 5 D). Collectively, these results demonstrate that CB2 receptors enhance obesity-associated insulin resistance.
###end p 68
###begin title 69
###xml 55 59 <span type="species:ncbi:10090">mice</span>
CB2 receptors potentiate insulin resistance in HFD-fed mice.
###end title 69
###begin p 70
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 722 726 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 731 733 731 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 774 776 774 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
A-C, Cnr2 knock-out reduces obesity-induced insulin resistance. WT and Cnr2 -/- mice were fed a ND or a HFD for 15 weeks A, Fasting glycemia, insulinemia, HOMA-IR; B, Blood glucose level during insulin tolerance tests in HFD-fed mice (p<0.05 by two way ANOVA). C, Hyperinsulinemic-euglycemic clamp in HFD-fed mice, as assessed by glucose turnover rate, whole body glycolysis and glycogen synthesis, following insulin stimulation. D, CB2 receptor activation increases insulin resistance. Blood glucose level during insulin tolerance tests in WT mice fed a HFD for 6 weeks and treated daily with an i.p injection of JWH-133 (3 mg/kg) or vehicle during the last 15 days of HFD (p<0.05 by two way ANOVA). * p<0.05 for HFD-fed Cnr2 -/- vs HFD-fed WT mice. # p<0.05 in HFD-fed WT vs ND-fed WT mice.
###end p 70
###begin title 71
CB2 receptors promote fatty liver
###end title 71
###begin p 72
###xml 184 185 184 185 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 185 191 185 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 6A</bold>
###xml 185 191 185 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g006"><bold>Fig 6A</bold></xref>
###xml 191 192 191 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 215 223 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 315 316 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 316 322 316 322 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 6A</bold>
###xml 316 322 316 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g006"><bold>Fig 6A</bold></xref>
###xml 322 323 322 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 408 409 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 409 415 409 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 6B</bold>
###xml 409 415 409 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g006"><bold>Fig 6B</bold></xref>
###xml 415 416 415 416 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 549 550 549 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 550 556 550 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 6B</bold>
###xml 550 556 550 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005844-g006"><bold>Fig 6B</bold></xref>
###xml 556 557 556 557 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
Obesity-associated fatty liver has been causally linked to adipose tissue inflammation and insulin resistance. As expected, WT mice fed a HFD for 15 weeks developed severe fatty liver (Fig 6A). In contrast, HFD-fed Cnr2 -/- animals exhibited minimal steatosis, as illustrated by the decrease in the steatosis score (Fig 6A) and the decline in liver triglyceride concentration, compared to HFD-fed WT animals (Fig 6B). In keeping with these results, administration of JWH-133 enhanced liver triglyceride accumulation in WT mice fed a HFD for 6 weeks (Fig 6B). Taken together, these findings indicate that CB2 receptors potentiate obesity-associated fatty liver.
###end p 72
###begin title 73
CB2 receptors promote the development of hepatic steatosis.
###end title 73
###begin p 74
###xml 3 7 3 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 152 160 152 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 232 239 232 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2&#8722;/&#8722;</italic>
###xml 351 353 351 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 377 388 377 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722; vs</italic>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
A, Cnr2 knock-out blunts steatosis. Representative liver tissue sections (magnification x100), mean steatosis score and hepatic triglycerides in WT and Cnr2 -/- mice fed a HFD for 15 weeks. B, Hepatic triglycerides in HFD-fed WT or Cnr2-/- mice for 15 weeks and in vehicle or JWH-133-treated (3 mg/kg) HFD-fed WT mice for 6 weeks. *p<0.05 for JWH-133 vs vehicle or for HFD-fed Cnr2 -/- vs HFD-fed WT mice.
###end p 74
###begin title 75
Discussion
###end title 75
###begin p 76
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
Our study unravels a previously unrecognized contribution of CB2 receptors to the pathogenesis of obesity associated-comorbodities via an impact on obesity-associated inflammation, insulin resistance and fatty liver.
###end p 76
###begin p 77
###xml 152 155 152 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Weisberg1">[4]</xref>
###xml 156 159 156 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Xu1">[7]</xref>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Kamei1">[27]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Kanda1">[28]</xref>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 432 436 432 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 1148 1153 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1276 1280 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 1285 1288 1285 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tnf</italic>
###xml 1419 1423 1419 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 1483 1487 1483 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Roche1">[29]</xref>
###xml 1489 1493 1489 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Matias1">[30]</xref>
###xml 1887 1891 1887 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Klein1">[15]</xref>
###xml 1893 1897 1893 1897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Miller1">[31]</xref>
###xml 1898 1902 1898 1902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Derocq1">[33]</xref>
###xml 1939 1941 1939 1941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vs</italic>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
###xml 1154 1158 <span type="species:ncbi:10090">mice</span>
###xml 1438 1443 <span type="species:ncbi:9606">human</span>
Recent studies have conclusively shown that adipose tissue and liver inflammation plays a major role in obesity-associated insulin resistance and NAFLD [4]-[7], [27], [28]. Our data indicate that during obesity progression, Cnr2 expression undergoes a strong increase in adipose tissue parallel to the development of fat inflammation, and a moderate induction in the liver. Tissue fractionation experiments show that enhancement of Cnr2 expression arises from the macrophage-enriched stromal vascular fraction of the adipose tissue and the non parenchymal liver cell fraction, whereas Cnr2 expression in adipocytes and hepatocytes remains negligible. Pharmacological activation of CB2 receptors has no significant impact on liver inflammation but promotes a significant enhancement of adipose tissue inflammation at an early stage. Indeed, administration of JWH-133 at the onset of inflammation, i.e. in mice fed a HFD for 6 weeks, increases fat macrophage infiltration and the related inflammatory response. Moreover, pharmacological and genetic CB2 receptor inactivation reduce adipose tissue and liver inflammation in the long term, as shown in ob/ob mice or animals fed a HFD for 15 weeks. Interestingly, in isolated fat pads, the CB2 receptor agonist JWH-133 upregulates Ccl2 and Tnf, demonstrating the direct impact of CB2 receptors to adipose tissue inflammation. Nevertheless, in light of previous data showing Cnr2 expression in human adipocytes and in adipocyte cell lines [29], [30], the contribution of adipocyte CB2 receptors to fat inflammation cannot be definitively ruled out. Mechanisms underlying the impact of CB2 receptors on macrophage recruitment remain to be determined. Potential pathways could involve enhanced chemotaxis and/or increased macrophage migration, considering reported stimulatory effects of CB2 receptors on these two functions in other conditions [15], [31]-[33]. The relative contribution of liver vs adipose tissue inflammation remains to be determined. Nevertheless, our data unravel the critical role of CB2 receptors in obesity-associated inflammation.
###end p 77
###begin p 78
###xml 90 93 90 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Weisberg1">[4]</xref>
###xml 94 97 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Xu1">[7]</xref>
###xml 374 382 374 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2 &#8722;/&#8722;</italic>
###xml 629 633 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Julien1">[23]</xref>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Cavuoto1">[34]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Starowicz1">[35]</xref>
###xml 892 896 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Starowicz1">[35]</xref>
###xml 898 902 895 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-JuanPico1">[36]</xref>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
Insulin resistance associated with obesity has been linked to adipose tissue inflammation [4]-[7]. In keeping with these studies, our data suggest that proinflammatory properties of adipose tissue CB2 receptors may contribute to the development of insulin resistance. Indeed, under HFD, JWH-133-treated WT mice show enhanced insulin resistance and fat inflammation, whereas Cnr2 -/- mice display improved insulin sensitivity and reduced fat inflammation. It should also be stressed that, aside from their impact on fat inflammation, CB2 receptors expressed by other insulin sensitive tissues, including skeletal muscle and liver [23], [34], [35] may also contribute to insulin resistance. In addition, deleterious effects of CB2 receptors on insulin secretion may also be expected, in light of the inhibition of insulin secretion triggered by CB2 receptors expressed in pancreatic beta cells [35], [36].
###end p 78
###begin p 79
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Postic1">[10]</xref>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 693 697 693 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccr2</italic>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Kamei1">[27]</xref>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Kanda1">[28]</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Weisberg2">[37]</xref>
###xml 938 942 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ccl2</italic>
###xml 1106 1110 1103 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 1153 1157 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Julien1">[23]</xref>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
Our results indicate that fatty liver, a hallmark of obesity-associated metabolic syndrome, is enhanced by the CB2 receptor agonist JWH-133 and blunted by Cnr2 knock-out. Recent data have conclusively shown a causal relationship between obesity-induced overproduction of fat inflammatory mediators such as Ccl2, insulin resistance and steatogenesis. Indeed, insulin resistance enhances the release of non-esterified fatty acids from adipose tissue, leading to increased fatty acid storage in hepatocytes [10]. Moreover, mice overexpressing Ccl2 specifically in adipose tissue exhibit insulin resistance and increased hepatic triglyceride content. Conversely, knock-out of Ccl2 or its receptor Ccr2, improves insulin sensitivity and prevents steatosis [27], [28], [37]. Therefore, it is tempting to speculate that CB2 receptors may enhance fatty liver at least partly by increasing adipose tissue inflammation and the related induction of Ccl2. Other steatogenic mechanisms may include enhancement of lipogenesis and/or inhibition of fatty acid beta-oxidation in hepatocytes, following direct activation of Cnr2. However, although expressed in the liver [23], CB2 receptors are undetectable in steatotic hepatocytes.
###end p 79
###begin p 80
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Engeli1">[38]</xref>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Gonthier1">[39]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Bluher1">[40]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Cote1">[41]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-DiMarzo1">[11]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Kunos1">[14]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-GaryBobo1">[42]</xref>
###xml 576 580 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Hezode1">[45]</xref>
###xml 851 854 851 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1108 1112 1108 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cnr2</italic>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
Recent studies in obese patients have reported elevated circulating levels of the endogenous CB2 ligand 2-arachidonoylglycerol [38] and increased production of the compound by fat cells [39]. These observations, together with our findings demonstrating induction of CB2 receptor in adipose tissue and liver, indicate that alike CB1 tone, the endogenous CB2 tone is increased during obesity [40], [41]. Clinical and experimental studies in obesity have also linked overactivation of CB1 receptors to body weight progression, insulin resistance and fatty liver [11], [14], [42]-[45]. Interestingly, although both receptors display convergent effects, pathways underlying CB1 effects are markedly different from those affected by CB2. Indeed, CB1 receptors mainly enhance food intake, reduce peripheral energy expenditure and enhance hepatic lipogenesis via CB1 receptors expressed by hepatocytes. In contrast, pharmacological modulation of CB2 receptors has no impact on either food intake or body weight progression and predominantly affects adipose tissue inflammation. It should however be pointed out that Cnr2 knock-out was associated with a slight reduction of body weight progression under HFD, that was not observed in WT animals exposed to CB2 agonists or antagonists. This discrepancy may result from developmental defects linked to lifelong absence of CB2 receptors or may be due to the short duration of treatment with the CB2 targeting molecules in our experiments. Nevertheless, our findings indicate that distinct CB1 and CB2 receptor-dependent pathways significantly contribute to the pathogenesis of insulin resistance and NAFLD.
###end p 80
###begin p 81
###xml 488 491 488 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-DiMarzo1">[11]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Pacher1">[13]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Kunos1">[14]</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Klein1">[15]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Mallat1">[12]</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Lotersztajn1">[17]</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Julien1">[23]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Hezode1">[45]</xref>
###xml 706 710 706 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005844-Mallat2">[48]</xref>
In conclusion, the present study uncovers the potent proinflammatory properties of CB2 receptors during experimental obesity and shows the deleterious impact of CB2 receptors on insulin resistance and fatty liver. These findings further document the crucial role of the endocannabinoid system in metabolic comorbidities associated to obesity, and unravel the previously unrecognized role of CB2 receptors. They also demonstrate that both CB1 and CB2 receptors display convergent effects, via complementary pathways [11], [13], [14]. Finally, our results add novel evidences underscoring the role of CB2 receptors in the pathogenesis of inflammatory disorders [15] and liver diseases [12], [17], [23], [45]-[48]. Lastly, our results suggest that CB2 receptor antagonism may open a novel therapeutic approach for the management of insulin resistance and fatty liver.
###end p 81
###begin p 82
We thank F. Pecker for helpful and constant guidance, C. Pavoine for helpful comments and S. Balustre for animal handling.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Abdominal obesity and metabolic syndrome.
###end article-title 84
###begin article-title 85
Obesity.
###end article-title 85
###begin article-title 86
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
###end article-title 86
###begin article-title 87
Obesity is associated with macrophage accumulation in adipose tissue.
###end article-title 87
###begin article-title 88
Inflammation and metabolic disorders.
###end article-title 88
###begin article-title 89
Obesity, inflammation, and insulin resistance.
###end article-title 89
###begin article-title 90
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
###end article-title 90
###begin article-title 91
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice.
###end article-title 91
###begin article-title 92
Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity.
###end article-title 92
###begin article-title 93
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice.
###end article-title 93
###begin article-title 94
Targeting the endocannabinoid system:to enhance or reduce?
###end article-title 94
###begin article-title 95
Endocannabinoids and Their Receptors in the Liver.
###end article-title 95
###begin article-title 96
The endocannabinoid system as an emerging target of pharmacotherapy.
###end article-title 96
###begin article-title 97
Endocannabinoids and liver disease. IV. Endocannabinoid involvement in obesity and hepatic steatosis.
###end article-title 97
###begin article-title 98
Cannabinoid-based drugs as anti-inflammatory therapeutics.
###end article-title 98
###begin article-title 99
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.
###end article-title 99
###begin article-title 100
CB2 receptors as new therapeutic targets during liver diseases.
###end article-title 100
###begin article-title 101
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury.
###end article-title 101
###begin article-title 102
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
###end article-title 102
###begin article-title 103
###xml 143 146 <span type="species:ncbi:10116">rat</span>
Utilisation of the method of Kalman filtering for performing the on-line computation of background metabolism in the free-moving, free-feeding rat.
###end article-title 103
###begin article-title 104
Practical aspects of indirect calorimetry in laboratory animals.
###end article-title 104
###begin article-title 105
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
###end article-title 105
###begin article-title 106
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
###end article-title 106
###begin article-title 107
3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
###end article-title 107
###begin article-title 108
The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy.
###end article-title 108
###begin article-title 109
AM630, a competitive cannabinoid receptor antagonist.
###end article-title 109
###begin article-title 110
Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.
###end article-title 110
###begin article-title 111
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.
###end article-title 111
###begin article-title 112
###xml 55 60 <span type="species:ncbi:9606">human</span>
Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes.
###end article-title 112
###begin article-title 113
Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.
###end article-title 113
###begin article-title 114
CB2 receptor-mediated migration of immune cells: it can go either way.
###end article-title 114
###begin article-title 115
###xml 51 56 <span type="species:ncbi:9606">human</span>
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.
###end article-title 115
###begin article-title 116
Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation.
###end article-title 116
###begin article-title 117
Effects of cannabinoid receptors on skeletal muscle oxidative pathways.
###end article-title 117
###begin article-title 118
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
###end article-title 118
###begin article-title 119
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.
###end article-title 119
###begin article-title 120
CCR2 modulates inflammatory and metabolic effects of high-fat feeding.
###end article-title 120
###begin article-title 121
###xml 55 60 <span type="species:ncbi:9606">human</span>
Activation of the peripheral endocannabinoid system in human obesity.
###end article-title 121
###begin article-title 122
###xml 60 65 <span type="species:ncbi:9606">human</span>
Identification of endocannabinoids and related compounds in human fat cells.
###end article-title 122
###begin article-title 123
###xml 77 82 <span type="species:ncbi:9606">human</span>
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity.
###end article-title 123
###begin article-title 124
###xml 106 109 <span type="species:ncbi:9606">men</span>
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
###end article-title 124
###begin article-title 125
###xml 113 117 <span type="species:ncbi:10116">rats</span>
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.
###end article-title 125
###begin article-title 126
Paracrine Activation of Hepatic CB(1) Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver.
###end article-title 126
###begin article-title 127
Cannabinoid receptors as therapeutic targets for obesity and metabolic diseases.
###end article-title 127
###begin article-title 128
###xml 76 87 <span type="species:ncbi:11103">hepatitis C</span>
Daily cannabis smoking as a risk factor for fibrosis progression in chronic hepatitis C. Hepatology
###end article-title 128
###begin article-title 129
CB1 cannabinoid receptor antagonism: a novel strategy for the treatment of liver fibrosis.
###end article-title 129
###begin article-title 130
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 87 98 <span type="species:ncbi:11103">hepatitis C</span>
Daily cannabis use, a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology
###end article-title 130
###begin article-title 131
Endocannabinoids as novel mediators of liver diseases.
###end article-title 131
###begin p 132
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 132
###begin p 133
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the INSERM, the Universite Paris-Val-de-Marne, and by grants (to SL) of the Agence Nationale de la Recherche and the Fondation pour la Recherche Medicale. V Deveaux was supported by a fellowship from the Association Francaise pour l'Etude du Foie, Y Ichigotani by a fellowship from the Agence Nationale de la Recherche and T Cadoudal by a fellowship from the Fondation pour la Recherche Medicale. A Bertola was successively supported by the Programme Hospitalier de Recherche Clinique (CHU of Nice) and the Association pour la Recherche sur le Cancer. Y Le-Marchand Brustel and P Gual are the recipients of an interface grant from CHU of Nice, and S Lotersztajn of an interface grant from AP-HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 133

